Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
6.55
+1.33 (25.48%)
At close: Feb 27, 2026, 4:00 PM EST
6.06
-0.49 (-7.48%)
After-hours: Feb 27, 2026, 7:59 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Product Testing
34.89K17.07K950.00901.00
Product Testing Growth
104.45%1696.32%5.44%-
Total
34.89K17.07K950.00901.00
Total Growth
104.45%1696.32%5.44%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
34.89K17.07K950.00901.00
United States Growth
104.45%1696.32%5.44%-
Total
34.89K17.07K950.00901.00
Total Growth
104.45%1696.32%5.44%-
Source: S&P Global Market Intelligence.